These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11101175)

  • 1. Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients.
    Duh MS; Walker AM; Lindmark B; Laties AM
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):356-61. PubMed ID: 11101175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disease duration on dose-response of inhaled budesonide in asthma.
    Selroos O
    Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.
    Busse WW; Pedersen S; Pauwels RA; Tan WC; Chen YZ; Lamm CJ; O'Byrne PM;
    J Allergy Clin Immunol; 2008 May; 121(5):1167-74. PubMed ID: 18405951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
    Chen YZ; Busse WW; Pedersen S; Tan W; Lamm CJ; O'Byrne PM
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study.
    Sheffer AL; Silverman M; Woolcock AJ; Díaz PV; Lindberg B; Lindmark B
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):48-54. PubMed ID: 15702816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial.
    Silverman M; Sheffer AL; Díaz PV; Lindberg B
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():14-20. PubMed ID: 16573704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma.
    Kemp J; Wanderer AA; Ramsdell J; Southern DL; Weiss S; Aaronson D; Grossman J
    Ann Allergy Asthma Immunol; 1999 May; 82(5):463-71. PubMed ID: 10353578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
    Weng JL; Zheng YS; Ma QF
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmologic findings in children with asthma receiving inhaled budesonide.
    Pelkonen A; Kari O; Selroos O; Nikander K; Haahtela T; Turpeinen M
    J Allergy Clin Immunol; 2008 Oct; 122(4):832-834. PubMed ID: 18760462
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports.
    Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
    Ther Drug Monit; 2013 Feb; 35(1):118-28. PubMed ID: 23318282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma.
    Hedlin G; Svedmyr J; Ryden AC
    Acta Paediatr; 1999 Jan; 88(1):48-51. PubMed ID: 10090547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of knemometric growth rates in group studies of children treated with exogenous glucocorticoids.
    Heuck C; Wolthers OD
    Ann Hum Biol; 1997; 24(5):411-8. PubMed ID: 9300118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled glucocorticoid treatment.
    O'Neil SE; Sitkauskiene B; Babusyte A; Krisiukeniene A; Stravinskaite-Bieksiene K; Sakalauskas R; Sihlbom C; Ekerljung L; Carlsohn E; Lötvall J
    Respir Res; 2011 Sep; 12(1):124. PubMed ID: 21939520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.
    Agustí A; De Stefano G; Levi A; Muñoz X; Romero-Mesones C; Sibila O; Lopez-Giraldo A; Plaza Moral V; Curto E; Echazarreta AL; Márquez SE; Pascual-Guàrdia S; Santos S; Marin A; Valdés L; Saldarini F; Salgado C; Casanovas G; Varea S; Ríos J; Faner R
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 35144989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review.
    Wijnants D; Stalmans I; Vandewalle E
    J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.